Briefly: Randomized research found that radiation treatment to the entire brain after surgery for tumors that had spread to the brain didn’t improve either survival or the time that patients remained able to function independently. Mice with muscle wasting and fat loss from cancer benefited from a commonly used diabetes drug.
In other headlines, Katie Couric received an award from Fordham University and called her work with colorectal cancer awareness “her greatest achievement.” A panel at the FDA has recommended approval of a new formulation of OxyContin that is less easy to tamper with. Online registration for the October 4th Strides for Life Walk/Run closes on October 1.
- Whole brain radiotherapy (WBRT) after surgery or focused brain radiation to treat brain tumors that have spread into the brain from other cancer sites doesn’t improve either overall survival time or the time that patients are able to function independently. It did extend time before cancer got worse within the brain and prevented some deaths directly caused by pressure within the brain compared to patients who were only observed after their initial surgery. R. Soffietti reported the results of a randomized study over more than 350 patients with brain metastases at the ECCO/ESMO Multidisciplinary Congress in Berlin.
- Mice with colon tumors treated with the diabetes drug rosiglitazone (Avandia®) gained weight despite having developed insulin resistance and initial weight loss. Mice with cancer who didn’t receive the drug lost weight and fat tissue. Scientist theorize that insulin resistance, which contributes to obesity and type 2 diabetes, actually is part of the muscle wasting and severe fat loss in cancer patients known as cancer cachexia. Martha Belury from the Department of Human Nutrition at the Ohio State University says that is it too early to know if the drug would combat cachexia in humans. Her team’s research is reported online in the International Journal of Cancer. More information about the study is available in an OSU press release.
- CBS Evening News anchor Katie Couric says that her work to wipe out colorectal cancer has been her greatest accomplishment. Accepting the Brien McMahon Award for Public Service at Fordham University, Couric recalls her desperate search for ” some kind of magic bullet that would make Jay well” during her husband Jay Monahan’s battle with colon cancer. After Monahan’s death, Couric had a colonoscopy on morning TV to raise awareness of the test and colorectal cancer prevention. She founded the National Colorectal Cancer Research Alliance and helped establish the Jay Monahan Center for Gastrointestinal Health in New York City.
- A joint meeting of Food and Drug Administration (FDA) pain and medication safety panels on September 24, 2009 recommended approval of a new formulation of the opiate painkiller OxyContin which is designed to make it harder to abuse. Currently OxyContin can be crushed into power which abusers can snort, smoke, or dissolve in water and inject providing a powerful, heroin-like effect. The new pills are coated with resin which makes them very difficult to crush. Dissolved in water, they form a gel. If approved by the FDA, Purdue Pharma, manufacturers of OxyContin, will no longer ship the older product but begin distributing the tamper-proof medication, marketing it as a “safer” version. An article , September 24, 2009. about the FDA panel decision written by Emily Walker was published on MedPage Today.
- Online registration for the annual Strides for Life/Get Your Rear in Gear Walk/Run closes on October 1, 2009. Strides for Life honors the memory of Dylan Cappel, who died of colon cancer at the age of 23 while training for a spot on the US Olympic rowing team. The Walk and Run will be held on October 4th at Lake Merced in San Francisco, sponsored by the Strides for Life Foundation.